Jefferies Financial Group Inc. Buys Shares of 779,545 The Chemours Company $CC

Jefferies Financial Group Inc. purchased a new position in The Chemours Company (NYSE:CC) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 779,545 shares of the specialty chemicals company’s stock, valued at approximately $15,996,000. Jefferies Financial Group Inc. owned approximately 0.52% of Chemours at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in the stock. Parallel Advisors LLC grew its position in Chemours by 10.9% during the first quarter. Parallel Advisors LLC now owns 5,366 shares of the specialty chemicals company’s stock valued at $118,000 after purchasing an additional 527 shares in the last quarter. Oregon Public Employees Retirement Fund increased its stake in shares of Chemours by 1.8% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 34,300 shares of the specialty chemicals company’s stock worth $404,000 after acquiring an additional 600 shares during the last quarter. Man Group plc boosted its position in Chemours by 0.4% during the second quarter. Man Group plc now owns 271,108 shares of the specialty chemicals company’s stock valued at $3,104,000 after purchasing an additional 979 shares during the last quarter. Rothschild Investment LLC grew its stake in Chemours by 87.0% in the fourth quarter. Rothschild Investment LLC now owns 2,698 shares of the specialty chemicals company’s stock valued at $32,000 after purchasing an additional 1,255 shares in the last quarter. Finally, Abel Hall LLC grew its stake in Chemours by 12.6% in the first quarter. Abel Hall LLC now owns 12,267 shares of the specialty chemicals company’s stock valued at $270,000 after purchasing an additional 1,369 shares in the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Denise Dignam purchased 3,378 shares of the firm’s stock in a transaction on Tuesday, August 11th. The shares were bought at an average cost of $14.95 per share, for a total transaction of $50,501.10. Following the transaction, the chief executive officer directly owned 339,916 shares of the company’s stock, valued at approximately $5,081,744.20. This trade represents a 1.00% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Shane Hostetter acquired 3,350 shares of the company’s stock in a transaction dated Thursday, August 6th. The shares were bought at an average price of $14.94 per share, for a total transaction of $50,049.00. Following the acquisition, the chief financial officer owned 102,698 shares in the company, valued at approximately $1,534,308.12. This trade represents a 3.37% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased 8,663 shares of company stock worth $130,601 in the last ninety days. Insiders own 0.85% of the company’s stock.

Chemours Stock Up 0.5%

Shares of CC stock opened at $15.85 on Friday. The Chemours Company has a 12 month low of $10.44 and a 12 month high of $28.67. The firm has a market cap of $2.39 billion, a PE ratio of -8.30 and a beta of 1.43. The stock has a 50 day moving average of $17.52 and a 200-day moving average of $20.00. The company has a quick ratio of 0.88, a current ratio of 1.66 and a debt-to-equity ratio of 18.98.

Chemours (NYSE:CC) last announced its quarterly earnings data on Tuesday, August 4th. The specialty chemicals company reported $0.42 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.49 by ($0.07). Chemours had a positive return on equity of 60.64% and a negative net margin of 5.00%.The company had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.65 billion. During the same quarter in the previous year, the business posted ($2.54) EPS. The company’s revenue was down 1.5% on a year-over-year basis. On average, equities analysts predict that The Chemours Company will post 0.87 EPS for the current year.

Chemours Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Friday, August 14th will be issued a $0.0875 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $0.35 dividend on an annualized basis and a yield of 2.2%. Chemours’s dividend payout ratio is -18.32%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Weiss Ratings lowered Chemours from a “sell (d)” rating to a “sell (d-)” rating in a research report on Thursday, August 6th. Truist Financial dropped their price objective on Chemours from $30.00 to $24.00 and set a “buy” rating on the stock in a report on Thursday, August 6th. Alembic Global Advisors reaffirmed an “overweight” rating and set a $30.00 price objective on shares of Chemours in a research report on Wednesday, May 13th. Zacks Research cut shares of Chemours from a “strong-buy” rating to a “strong sell” rating in a research note on Tuesday, August 11th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Chemours from $22.00 to $15.00 and set a “neutral” rating for the company in a research report on Thursday, August 13th. Five investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, Chemours currently has a consensus rating of “Hold” and an average price target of $20.10.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.